Chronic Neutrophilic Leukemia
What's New
Last Posted: Apr 28, 2024
- Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies.
Seon Young Kim, et al. Annals of diagnostic pathology 2024 0 152317 - CSF3R-mutated chronic neutrophilic leukemia: long-term outcome in 19 consecutive patients and risk model for survival.
Szuber Natasha, et al. Blood cancer journal 2018 0 (2) 21 - [Analysis of Clinical Features and Prognosis of Patients with Chronic Neutrophil Leukemia].
Guo Yu-Jie, et al. Zhongguo shi yan xue ye xue za zhi 2020 0 (1) 82-87 - An atypical chronic neutrophilic leukemia patient harboring ASXL1 and NRAS mutations associated with monoclonal plasma cell dyscrasia presenting as hemopericardium.
Han Qiaoyan, et al. Annals of hematology 2020 0 (1) 273-275 - Use of the «BCR/ABL - multitest» kit in the algorithm of laboratory diagnostics of oncohematological diseases: economic aspects.
Gorbenko A S, et al. Klinicheskaia laboratornaia diagnostika 2021 0 (9) 571-576 - [CSF3R, ASXL1,SETBP1, JAK2 V617F and CALR mutations in chronic neutrophilic leukemia].
Cui Yajuan, et al. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2014 0 (12) 1069-73 - Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
Dao Kim-Hien T, et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 0 (10) 1006-1018 - Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia.
Adam Franziska C, et al. Current oncology (Toronto, Ont.) 2022 0 (2) 805-815 - CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
Qian Yi, et al. Annals of hematology 2021 4 - Local Coverage Determination (LCD): Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid Diseases (L37606)
The U.S. Centers for Medicare & Medicaid Services - CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia.
Zhang Yang, et al. Cancer 2018 6 - Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management.
Elliott Michelle A et al. American journal of hematology 2018 Aug 93(4) 578-587 - Targeted next-generation sequencing identifies clinically relevant mutations in patients with chronic neutrophilic leukemia at diagnosis and blast crisis.
Langabeer S E, et al. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2017 7 - [The clinical characteristics, gene mutations and prognosis of chronic neutrophilic leukemia].
Cui Y J, et al. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2017 1 (1) 28-32 - Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.
Ouyang Yuan, et al. Oncotarget 2017 2 - Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.
Shou Li-Hong, et al. PloS one 2017 0 (2) e0171608 - Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
Maxson Julia E, et al. The New England journal of medicine 2013 5 (19) 1781-90 - CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.
Pardanani A, et al. Leukemia 2013 9 (9) 1870-3 - Chronic neutrophilic leukemia
From NCATS Genetic and Rare Diseases Information Center
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 14, 2024
- Content source: